http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-078860-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37d33af0ced51baa9690feaaf2449427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ad709b23f091a687ba167879b5db7c0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10 |
| filingDate | 2010-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-078860-A1 |
| titleOfInvention | PHARMACEUTICAL ASSOCIATIONS, PHARMACEUTICAL COMPOSITIONS, MEDICATION AND METHOD FOR THE TREATMENT OF ANIMALS |
| abstract | Anthelmintic pharmaceutical associations containing iodinated aromatic compounds, such as dysophenol or nitroxynil, with other pharmaceutical active ingredients that are intended to treat animals. More specifically, pharmaceutical compositions containing dysophenol or nitroxynil with at least one other anthelmintic active ingredient, selected from benzimidazoles, thiabendazole, levamisole or tetramisol salts, avermectins or milbemycins and, more preferably, levamisole salts selected from chloride or phosphate of Levamisole Also, medicines and methods of treatment of animals comprising those anthelmintic drugs. Claim 7: Pharmaceutical compositions, characterized in that they contain as active ingredients the compound disophenol in amounts ranging from 0.5% to 50% by weight, or a nitroxynil compound or its pharmaceutically acceptable salts in amounts ranging from 0.3% to 30% by weight, and a levamisole compound or its pharmaceutically acceptable salts, in amounts ranging from 0.3% to 30% by weight, in addition to pharmaceutically acceptable adjuvant agents. Claim 17: Pharmaceutical compositions according to claim 7, characterized in that they contain concomitantly disophenol and nitroxynil in combination with pharmaceutically effective amounts for parasite control of at least one active ingredient selected from salts of levamisole or tetramisol, thiabendazole mebendazole albendazole, sulfoxide of albendazole, flubendazole, oxifendazole, fenbendazole, oxibendazole, abamectin, ivermectin, doramectin, eprinomectin, selamectin, moxidectin, milbemycin and milimemycin oxime, preferably levamisole in the form of its salts prepared with hydrochloric acid or phosphoric acid, acceptable agents in pharmacy Claim 23: Medication according to any of claims 20 to 22, characterized in that it is produced in solid form or in liquid form, by means of its combinations with vehicles and other components acceptable in pharmacy. |
| priorityDate | 2009-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.